ir@perkinelmer.com (781) 663 - 6900 940 Winter Street Waltham, MA 02451 United States www.perkinelmer.com
A copy of our Annual Report on Form 10-K for the fiscal year ended December 30, 2018 as filed with the Securities and Exchange Commission, except for exhibits, will be furnished without charge to any shareholder upon written or oral request to PerkinElmer, Inc., 940 Winter Street, Waltham, Massachusetts 02451, Attention: Investor Relations
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to PerkinElmer, Inc. Perkinelmer Inc provided additional information to their SEC Filing as exhibits Exhibit 10.16: Perkinelmer, Inc. Savings Plan Amended And Restated Effective January 1, 2021 Exhibit 21: Subsidiaries Of Perkinelmer, … Recent 13D Filings for PERKINELMER INC (PKI) Since 2020, there have been 14 Schedule 13D forms (beneficial ownership report) filed for the company PERKINELMER INC (stock symbol PKI) by 6 beneficial owners. A schedule 13D is filed when a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company's equity securities. 2021-04-01 The information contained in the Company’s filings with SEC, including in the Company’s Form 10-K for the fiscal year ended December 29, 2019 identifies other important factors that could cause actual results to differ materially from those stated in or implied by the forward-looking statements herein. PerkinElmer Inc. secarticle SEC filings breakout by MarketWatch. View the PKI U.S. Securities and Exchange Commission reporting information.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to PerkinElmer, Inc. Perkinelmer Inc provided additional information to their SEC Filing as exhibits Exhibit 10.16: Perkinelmer, Inc. Savings Plan Amended And Restated Effective January 1, 2021 Exhibit 21: Subsidiaries Of Perkinelmer, … Recent 13D Filings for PERKINELMER INC (PKI) Since 2020, there have been 14 Schedule 13D forms (beneficial ownership report) filed for the company PERKINELMER INC (stock symbol PKI) by 6 beneficial owners. A schedule 13D is filed when a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company's equity securities. 2021-04-01 The information contained in the Company’s filings with SEC, including in the Company’s Form 10-K for the fiscal year ended December 29, 2019 identifies other important factors that could cause actual results to differ materially from those stated in or implied by the forward-looking statements herein.
We provide solutions for the diagnostics, life sciences, food and applied markets.
ING Groep NV boosted its holdings in shares of KeyCorp (NYSE:KEY) by 199.8% during the 4th quarter, according to its most recent 13F filing with the SEC.
We provide solutions for the diagnostics, life sciences, food and applied markets. PerkinElmer Inc. all SEC filings breakout by MarketWatch. View the PKI U.S. Securities and Exchange Commission reporting information. SEC filings and transcripts for Perkinelmer, Inc., including financials, news, proxies, indentures, prospectuses, and credit agreements ir@perkinelmer.com (781) 663 - 6900 940 Winter Street Waltham, MA 02451 United States www.perkinelmer.com PerkinElmer Inc. secarticle SEC filings breakout by MarketWatch.
PERKINELMER INC (Filer) CIK: 0000031791 (see all company filings) IRS No.: 042052042 | State of Incorp.:MA | Fiscal Year End: 0102 Type: 10-K | Act: 34 | File No
SEC Form Name Description Date PERKINELMER INC (Filer) CIK: 0000031791 (see all company filings) IRS No.: 042052042 | State of Incorp.:MA | Fiscal Year End: 0102 Type: 10-Q | Act: 34 | File No Search SEC Documents. To search SEC.gov and Investor.gov for public statements, proposed and final rules, enforcement actions, educational materials, and other documents, enter keywords or phrases below. Your feedback is welcome, contact webmaster@sec.gov. This search will not retrieve company filings. IR Home; Financial Information. Annual Reports; Quarterly Results; SEC Filings; Sales Tables; Fact Sheet; News & Events. News; Events & Presentations; Stock Information PerkinElmer, Inc. SEC Filing - Proxy Statement (definitive) (DEF 14A) March 10, 2021 SEC Filings Wed, Mar. 10 Struggling defensive sectors losing even more appeal ahead of more stimulus: At the Open Portions of PerkinElmer, Inc.’s Definitive Proxy Statement for its Annual Meeting of Shareholders to be held on April 23, 2019 are incorporated by reference into Part III of this Form 10-K.
Please disable your ad-blocker and refresh. IR Home; Financial Information. Annual Reports; Quarterly Results; SEC Filings; Sales Tables; Fact Sheet; News & Events. News; Events & Presentations; Stock Information
See the company profile for PerkinElmer, Inc. (PKI) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their
SEC Filings. Connect with Boston Scientific Investor Relations. Investor relations contact.
Hur manga vaningar ar turning torso
Mar 9, 2021 PerkinElmer (NYSE:PKI) announced today that it completed its previously another $3 million in an equity offering, according to an SEC filing. Prahlad has made over 3 trades of the Perkinelmer stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 10636 units of PKI As the world's largest independent supplier of medical and industrial imaging components, we are proud to offer an expanded portfolio of flat panel detectors and PerkinElmer produces analytical instruments, genetic testing and diagnostic on Improving Human and Environmental Health · SEC filings for PerkinElmer, Inc. Perkinelmer - Managed the global financial reporting and consolidation process for over 90 domestic Assist the external reporting group with SEC filings in… Identify the previous filing by registration statement number, or the Form or Schedule To assist you in reviewing the proxy statement for the PerkinElmer, Inc. 2019 Pursuant to applicable SEC rules, presented below is the ratio of The biography of West Pharmaceutical Services, Inc. Board Member Robert Friel, Retired Chairman and Chief Executive Officer of PerkinElmer, Inc. a review of United States Securities and Exchange Commission ("SEC") filings Defendant Gregory L. Summe ("Summe") was PerkinElmer's Chief Executive.
0001193125-21-099191.pdf. 0001193125-21-099191.rtf.
Luuletused kevadest
splendor plant allabolag
jens nyström wikipedia
schoolsoft värmdö kommun
escort didi
fryshuset kalmar
hvad betyder cis
Feb 3, 2021 the safe harbor statements that we have outlined in our earnings press release issued earlier this afternoon and also those in our SEC filings.
We provide solutions for the diagnostics, life sciences, food and applied markets. PerkinElmer Inc. all SEC filings breakout by MarketWatch. View the PKI U.S. Securities and Exchange Commission reporting information. SEC filings and transcripts for Perkinelmer, Inc., including financials, news, proxies, indentures, prospectuses, and credit agreements ir@perkinelmer.com (781) 663 - 6900 940 Winter Street Waltham, MA 02451 United States www.perkinelmer.com PerkinElmer Inc. secarticle SEC filings breakout by MarketWatch.
Special pedagogik 1
läsa litteraturvetenskap på distans
Mar 4, 2021 “SEC Filings,” and the documents incorporated by reference into the prospectus and prospectus supplement. While PerkinElmer may elect to
Please disable your ad-blocker and refresh. IR Home; Financial Information. Annual Reports; Quarterly Results; SEC Filings; Sales Tables; Fact Sheet; News & Events. News; Events & Presentations; Stock Information See the company profile for PerkinElmer, Inc. (PKI) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their SEC Filings. Connect with Boston Scientific Investor Relations. Investor relations contact.
SEC Filing Keyword Search . Group. Filing date Form Description Filing Group View; 03/30/21: DEF 14A: Official notification to shareholders of matters to be brought to a vote ("Proxy") Proxy Filings. 0001193125-21-099191.pdf. 0001193125-21-099191.rtf. 0001193125-21-099191.xls. View HTML: 03/30
A copy of our Annual Report on Form 10-K for the fiscal year ended December 30, 2018 as filed with the Securities and Exchange Commission, except for exhibits, will be furnished without charge to any shareholder upon written or oral request to PerkinElmer, Inc., 940 Winter Street, Waltham, Massachusetts 02451, Attention: Investor Relations, Telephone: (800) 762-4000.
A copy of our Annual Report on Form 10-K for the fiscal year ended December 31, 2017 as filed with the Securities and Exchange Commission, except for exhibits, will be furnished without charge to any shareholder upon written or oral request to PerkinElmer, Inc., 940 Winter Street, Waltham, Massachusetts 02451, Attention: Investor Relations, Telephone: (800) 762-4000. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus.